Satavaptan

Satavaptan is a vasopressin receptor antagonist used in the treatment of hyponatremia (low blood sodium levels) associated with cirrhosis, and heart failure. It was developed by Sanofi-Aventis.

Etymology

The term "Satavaptan" is derived from the Sanskrit word "Sata", meaning "hundred", and "vaptan", which is a derivative of the term "vasopressin antagonist". This name signifies the drug's ability to antagonize the effects of vasopressin, a hormone that regulates the body's water balance, on a hundred different levels.

Mechanism of Action

Satavaptan works by blocking the action of vasopressin, a hormone that regulates the body's water balance. This results in an increase in urine production, which helps to raise blood sodium levels.

Clinical Use

Satavaptan is used in the treatment of hyponatremia associated with conditions such as cirrhosis and heart failure. It is administered orally and is available in tablet form.

Side Effects

Common side effects of Satavaptan include dry mouth, thirst, and increased urination. In some cases, it may also cause low blood pressure (hypotension), dizziness, and kidney problems.

Related Terms

• Vasopressin receptor antagonist
• Hyponatremia
• Cirrhosis
• Heart failure
• Sanofi-Aventis

See Also

• Vasopressin
• Sanskrit

Satavaptan Resources
Latest articles Most recent articles Ongoing trials	Wikipedia